Vr Adviser, LLC Portfolio Holdings

Vr Adviser, LLC

  • $606 Million
  • Q4 2024

Vr Adviser, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $606 Million distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $109M, Viridian Therapeutics, Inc.\De with a value of $74.4M, Pharvaris N.V. with a value of $61.7M, Kal Vista Pharmaceuticals, Inc. with a value of $52.9M, and Dyne Therapeutics, Inc. with a value of $51.2M.

Examining the 13F form we can see an decrease of $360M in the current position value, from $966M to 606M.

Vr Adviser, LLC is based out at New York, NY

Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.

Portfolio value $606 Million
Healthcare: $606 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $606 Million
  • Prior Value $966 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 3 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email